» Articles » PMID: 35372584

Diabetes Mellitus Diagnosis and Screening in Australian General Practice: A National Study

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2022 Apr 4
PMID 35372584
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To investigate the epidemiology of diabetes diagnosis and screening in Australian general practice.

Methods: Cross-sectional study using electronic health records of 1,522,622 patients aged 18+ years attending 544 Australian general practices (MedicineInsight database). The prevalence of diagnosed diabetes and diabetes screening was explored using all recorded diagnoses, laboratory results, and prescriptions between 2016 and 2018. Their relationship with patient sociodemographic and clinical characteristics was also investigated.

Results: Overall, 7.5% (95% CI 7.3, 7.8) of adults had diabetes diagnosis, 0.7% (95% CI 0.6, 0.7) prediabetes, and 0.3% (95% CI 0.3, 0.3) unrecorded diabetes/prediabetes (elevated glucose levels without a recorded diagnosis). Patients with unrecorded diabetes/prediabetes had clinical characteristics similar to those with recorded diabetes, except for a lower prevalence of overweight/obesity (55.5% and 69.9%, respectively). Dyslipidaemia was 1.8 times higher (36.2% vs. 19.7%), and hypertension was 15% more likely (38.6% vs. 33.8%) among patients with prediabetes than with diabetes. Diabetes screening (last three years) among people at high risk of diabetes was 55.2% (95% CI 52.7, 57.7), with lower rates among young or elderly males.

Conclusions: Unrecorded diabetes/prediabetes is infrequent in Australian general practice, but prediabetes diagnosis was also lower than expected. Diabetes screening among high-risk individuals can be improved, especially in men, to enhance earlier diabetes diagnosis and management.

Citing Articles

Assessment of sex disparities in prevalence of diagnosed and undiagnosed diabetes mellitus: results from the Bangladesh demographic and health survey data.

Suhel S, Akther N, Islam S, Dhor N, Ahmed M, Hossain A BMC Endocr Disord. 2024; 24(1):265.

PMID: 39696101 PMC: 11653888. DOI: 10.1186/s12902-024-01788-x.


The impact of gut microbial dysbiosis on the atrophy of the hippocampus and abnormal metabolism of N-acetyl aspartate in type 2 diabetic rats.

Zhu Z, Chen Q, Jiang G, Liang Y, Shen J, Wu J Heliyon. 2024; 10(12):e33152.

PMID: 38994099 PMC: 11238125. DOI: 10.1016/j.heliyon.2024.e33152.


Periodic acid-Schiff staining in oral exfoliative cytology of diabetic patients: The odyssey for noninvasive screening - A systematic review and meta-analysis.

Aniyan K, Lakshmi K, Ganesan A Dent Res J (Isfahan). 2023; 20:73.

PMID: 37483895 PMC: 10361261.


Diabetes mellitus monitoring and control among adults in Australian general practice: a national retrospective cohort study.

Zheng M, Bernardo C, Stocks N, Hu P, Gonzalez-Chica D BMJ Open. 2023; 13(4):e069875.

PMID: 37185189 PMC: 10151933. DOI: 10.1136/bmjopen-2022-069875.


Dynamic Detection of HbA1c Using a Silicon Nanowire Field Effect Tube Biosensor.

Chen H, Deng L, Sun J, Li H, Zhu X, Wang T Biosensors (Basel). 2022; 12(11).

PMID: 36354424 PMC: 9688244. DOI: 10.3390/bios12110916.

References
1.
Manski-Nankervis J, Thuraisingam S, Sluggett J, Kilov G, Furler J, ONeal D . Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study. BMC Fam Pract. 2019; 20(1):29. PMC: 6378720. DOI: 10.1186/s12875-019-0915-x. View

2.
Longato E, Di Camillo B, Sparacino G, Saccavini C, Avogaro A, Fadini G . Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy). Nutr Metab Cardiovasc Dis. 2019; 30(1):84-91. DOI: 10.1016/j.numecd.2019.08.017. View

3.
Busingye D, Gianacas C, Pollack A, Chidwick K, Merrifield A, Norman S . Data Resource Profile: MedicineInsight, an Australian national primary health care database. Int J Epidemiol. 2019; 48(6):1741-1741h. DOI: 10.1093/ije/dyz147. View

4.
Shimodaira M, Okaniwa S, Hanyu N, Nakayama T . Corrigendum to "Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population". J Diabetes Res. 2017; 2017:7072538. PMC: 5632868. DOI: 10.1155/2017/7072538. View

5.
Gonzalez-Chica D, Bowden J, Miller C, Longo M, Nelson M, Reid C . Patient-reported GP health assessments rather than individual cardiovascular risk burden are associated with the engagement in lifestyle changes: population-based survey in South Australia. BMC Fam Pract. 2019; 20(1):173. PMC: 6911269. DOI: 10.1186/s12875-019-1066-9. View